Invesco India Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Invesco India Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹ & Lump. ₹1000

AUM (Fund size)

₹0 Cr

Lock In Period

N/A

Expense Ratio

N/A

Exit Load

If units are redeemed/switched out on or before 3 months from the date of allotment: 0.50%If units are redeemed/switched-out after 3 months: NilSwitch between the Plans under the Scheme: Nil

Benchmark

BSE Healthcare Total Return

Invesco India Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M0.000.4210.92
6M0.002.6018.13
1Y0.005.7040.20
3Y0.0015.18109.01

Portfolio Analysis

  • Equity:
  • Debt:
  • Others
As on:
View allocation % by
No Data Found
No Data Found

About Fund Invesco India Pharma and Healthcare Fund Growth

Invesco India Pharma and Healthcare Fund Growth managed by Invesco Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹0 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of . Under the expert guidance of Aditya Khemani ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Aditya Khemani

Mr. Aditya holds B.Com (Hons) and PGDM degree from IIM, Lucknow. He has over 6 years of experience in Research. Prior to this, he worked with SBI Funds Management India Private Limited Senior Manager - Equity Research from March 2007 to September 2007, Prudential ICICI Asset Management Company India Private Limited Assistant Manager - Equity Research from December 2005 to February 2007, Morgan Stanley Advantage Services Private Limited Research Associate from May 2005 to November 2005.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
Motilal Oswal Quant Fund Growth0254 CR1.81
ICICI Prudential Transportation and Logistics Fund Growth23,951 CR2.06
HDFC Transportation and Logistics Fund Growth01,955 CR2.15
Fund Name1Y3Y
This FundMotilal Oswal Quant Fund Growth4.70460
This FundICICI Prudential Transportation and Logistics Fund Growth22.310593.9496
This FundHDFC Transportation and Logistics Fund Growth22.6599101.7596

Invesco India Pharma and Healthcare Fund Growth FAQs

Invesco India Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Invesco India Pharma and Healthcare Fund Growth is . This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Invesco India Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : %
  • 6 Months : %
  • 1 Year : %
  • 3 Years : %
Returns of Invesco India Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ as on undefined NaN,NaN. Since inception, the return has been 0.00%.

You can invest in Invesco India Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Invesco India Pharma and Healthcare Fund Growth is ₹0 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Invesco India Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.